Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Cyclophosphamide for Antibiotics-unresponsive MALT Lymphoma
NCT04604028Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
Beyond the preview
Go deeper on NCT04604028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04604028.